Blog / Archives
Rayno Biopharma Stocks at ASCO: ARRY, CLVS, RXDX
Biotech Indices Can't Break Through Triple Top IBB at $365, XBI at $239 Red and green day Biotech stocks were mixed today with the major indices holding the flat line. However with all of the...
Biotech (IBB) 2015 Triple Top Is Here ! NASDAQ Hits New High…Update
Update-1 Mixed Market but CAR-T stocks soar Biotechs could not break through the top today and were down about 0.5%. The XBI and XLV did a little better almost flat. Red and green were just about...
Regulatory News for Rare Disease Products-Hot Stocks: BLUE,ICPT,SRPT …Updates
Update-2 uniQure up on deal with BMY (CURE) Cardiovascular Deal with Bristol Myers (BMY) The closing of the uniQure deal with Bristol Myers triggered a $50M payment. Three collaboration targets in...
Rayno Life Science Stocks Move Higher: CLVS, RHHBY-ASCO Preview
Rayno Biopharmaceutical Stocks- ASCO Plays or Not Large Caps Rule Clovis Oncology (CLVS) up 16.7%, 79% YTD to $100 level! Several data CLVS Presentations for ASCO including two oral and six posters...
Hot Biotech Sector: Mid-Caps Have Both M&A and Pipeline Premiums
Valuations Step-Up With More Deals Prior to the acquisition of Pharmacyclics (PCYC) by Abbvie (ABBV) for $20B, the top price paid for an emerging biotech company was in the $10B range. Two...
Biotechs Tag Along With Broad Market Rally: FBT Up 3%
Jobs Report Drive Stocks Higher-DOW Up 1.5% Stocks moved higher on the "goldilocks" job report which showed a gain of 223k added in April. The jobs number was too high to raise concerns about an...
M&A Sparks Biotechs: Alexion Buys Syngeva for $8.4B…Update-1
Orphan Drugs-The Latest Hot Spot in Biotech Large Cap Biotechs Were Red-Specualtive Stocks Were Green XBI 214.9 up 2.36% GEVA $203.4 up 112% NASDAQ 4919 down 0.4% Rare Disease Companies Merge:...
Surveying the Damage with Rayno Life Science Stocks…2015 YTD
Biotech Bounce-Caution on New Positions IBB up 2% at 340 support level Most biotech stocks are green as of early trading on May 1. Although the sector has taken a beating since April 23 most ETFs...
Biotech Buzz Is Broken…Update 4/30…#2
Gilead (GILD) Gilead Beats Q1 Estimates: $7.4B Sales HCV , EPS $2.94, stock up 2% after hours XBI Down Another 4% Down 12.84% in Five Days Weak Tape and Sell-Off Continues...4/30...NASDAQ at 4991...
Tech Hot Biotech Not: ALXN,BIIB…Update 4/26
Can Biotech Leadership Continue Up 20% YTD Biotech stocks were roughed up on Friday with a potential market rotation out of healthcare into technology. The XLK Technology SPDR was up 4% for the week...